| INTRODUC TI ON
Diabetic nephropathy (DN) is a syndrome characterized by the presence of pathological quantities of urine albumin excretion, diabetic glomerular lesions, and loss of glomerular filtration rate (GFR) in diabetic patients. DN patients have structural and functional changes in the kidney, with a mesangial expansion, thickening of the basement membrane, and nodular glomerulosclerosis in the glomeruli. 1, 2 All these kidney changes favor the recruitment and activation of immune cells and secretion of pro-inflammatory cytokines.
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As our knowledge of DN expands, some inflammatory cytokines have emerged as being intimately involved in the pathogenesis of DN. The increased concentration of IL-10 in the serum samples from diabetic patients with DN and its association with disease severity suggest that this cytokine could be contributing towards DN progression. 3 
IL-10 is a potent immunoregulatory cytokine produced by Th2
and Treg cells that has cytoprotective effects and also inhibits production of pro-inflammatory cytokines. 4 Although the role of IL-10 in DN has not been well described, there are several reports that allow speculating about its role in the pathology. IL-10 at the renal level is produced by the mesangial cells, and its abnormal increase generates mesangial cells proliferation which causes changes in the glomerular and interstitial tubules such as hypertrophy, glomerular membrane thickening, and albuminuria that together lead to renal failure. Based on the insufficient information on the role of these variants in DN, it was our interest to evaluate the association of the IL10 gene polymorphisms -1082G>A, -819C>T and -592C>A with DN in a Mexican population.
| MATERIAL S AND ME THODS

| Subjects
One hundred and twenty-eight patients diagnosed with DN and 150 control subjects (CS) were enrolled to this study, all of them from western Mexico. DN patients from the Nephrology Service of the Hospital No. 46 from the Instituto Mexicano del Seguro Social in Guadalajara, Jalisco, Mexico were recruited and the diagnosis of T2DM was according to ADA criteria. 12 The nephropathy was evaluated based on estimated Glomerular Filtration Rate (eGFR) less than 25 mL/min and proteinuria of 300 mg/24 hour. 
| Laboratory assessment
The evaluation included demographic features and clinical assessment: leukocyte count, blood pressure, glycosylated hemoglobin, serum glucose, urea, and creatinine, also total cholesterol, and triglyceride; the results were obtained by biochemical methods. The eGFR was calculated by CKD-EPI formula.
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| Genotyping
Blood samples were collected from all subjects, and genomic DNA was then extracted using modified Miller´s method. 15 To evaluate IL10 promoter polymorphisms -1082 G>A, -819 C>T and -592 C>A,
we use a polymerase chain reaction-restriction fragment length polymorphism method (PCR-RFLP) using the primers and reaction conditions described elsewhere. 16 of variance were used for nonparametric distribution data. IL10 haplotypes were coded according to the allele at each locus; the first letter refers to the -1082 (G or A), the second to the -819 (C or T), and the third to the -592 (C or A) alleles. Haplotypes inference was performed by EM algorithm using the SHEsis program (https://analysis.
| Statistical analysis
bio-x.cn/myAnalysis.php), and linkage disequilibrium was estimated using the Lewontin D' measure. Moreover, 40% of DN patients had hypertension.
| RE SULTS
| Clinical evaluation of the study groups
One hundred and fifty healthy volunteers (mainly blood donors) served as controls subject (CS), which were matched to patients by age and sex. None of the CS had hypertension, diabetes, or renal damage during the protocol trail.
| Genotypic and allelic frequencies of IL10 variants
Allelic and genotypic frequencies of IL10 gene polymorphisms (-1082A>G, -819C>T, and -592C>A) were calculated in all subjects to determine possible polymorphisms involvement in DN susceptibility ( Table 2 ). All variants were in Hardy-Weinberg equilibrium in CS (P > 0.05). Polymorphisms analysis showed that -1082AA homozygous genotype was the most frequent among tested groups, regarding the -819C>T and -592C>A polymorphisms, heterozygous was the most frequent genotype. Allelic frequencies of all three polymorphisms showed no significantly different distribution pattern between CS and DN, and none of the genetic models were associated with the risk of developing DN (P > 0.05).
| Haplotype analysis approach
The haplotype block structure (Figure 1 ) was determined for the three polymorphisms in both study groups, and strong linkage disequilibrium was observed with each other (D′ > 0.7), so further analyses were performed with haplotypes instead of individual polymorphisms.
Haplotype frequencies and their corresponding genotypes for patients and CS are shown in Table 3 . Eight haplotypes were inferred from IL10 gene polymorphisms using EM algorithm and their frequen- TA B L E 3 Inference and analysis of IL10 polymorphisms haplotypes (-1082, -819, -592) between DN patients and CS F I G U R E 2 Clinical and biochemical features of DN patients according to IL10 haplotypes. Serum glucose (A), urea (B), creatinine (C), and eGFR (D) according to IL10 haplotypes. The data were compared using Kruskal-Wallis test. Haplotypes were inferred from homozygous subjects to IL10 -1082A>G, -819C>T, and -592C>A polymorphisms. DN, diabetic nephropathy; eGFR, estimated glomerular filtration rate. Data were expressed as median and interquartile range.
CS provided negative results, the distribution of IL10 haplotype frequencies showed significant differences. Specifically, the haplotype ATC (-1082A/-819T/-592C) of the IL10 gene was significantly more frequent in DN patients than in CS (P = 0.0007; OR = 3.686, 95% CI: 
| D ISCUSS I ON
DN is the most common microvascular complication in diabetes patients, and the occurrence has no a complete association with hyperglycemia, suggesting that genetic factors may be involved in the development of DN. 18 Previous studies from different populations have shown that some cytokine genotypes are associated with an increased susceptibility to DN. [19] [20] [21] In this study, we analyzed the IL10 gene polymorphisms -1082A>G, -819C>T, and -592C>A as potential genetic markers related to progression of DN. Nevertheless, the individual results of these three polymorphisms showed that none of them were associated to DN risk (P > 0.05). Previous studies evaluating the role of IL10 polymorphisms in populations with different genetic ancestry observed inconsistent results on whether these polymorphisms confer DN susceptibility. 7, 9, 11, 22 Collectively, these studies suggest that individually, IL10 polymorphisms could be specific susceptibility markers for some Asian and African populations, but not for the Iranian or Mexican population. It has been demonstrated that Hispanics, African, and Asians are the main populations with marked differences in the inheritance of IL10 genotypes; in this sense, it has been well-documented that ethnicity greatly influences the distribution of allele frequencies of cytokine polymorphisms. 23 Thus, this could be contributing to discrepancies showed between our results and those from other populations.
IL10 gene polymorphisms (-1082A>G, -819C>T, and -592C>A) have also been evaluated as risk markers to other inflammatory diseases in population from Western Mexico 17,24,25 but similar to our results, they have not found a statistically significant association between these markers and disease susceptibility; however, ATC haplotype was associated with systemic lupus erythematosus (SLE) susceptibility, which is strongly associated with nephropathy. 26 In the present study, we observed that ATC haplotype In addition, ATC haplotype has been associated with IL-10 soluble levels production and could indirectly contribute to DN progression. 26 Other studies have observed a direct proportional serum level between IL-10 and TGF. Therefore, renal cell hypertrophy and extracellular matrix accumulation, observed in DN could be do to high TGF levels. 25 In addition, high IL-10 levels could promote mesangial deposition of immune complexes, thereby contributing to glomerular injury progression. 27 Also, an increased IL-10 concentrations in serum predict albuminuria and correlate with the severity of diabetic nephropathy.
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Also, GTA haplotype showed an association with DN susceptibility, in accordance with results observed in other population. 10 Despite GTA was associated to higher DN susceptibility than ATC haplotype (OR 4.02 vs OR 3.60, respectively), GTA haplotype is extremely rare (14.9%) in Mexican population, 28 thus, GTA could be barely related to DN risk. GTA haplotype and serum IL-10 level association have been observed in other pathologies, 10 however more studies, as clinical trials and in silico analysis, are required to confirm this association.
Our results have two significant limitations. First, study crosssectional design, which means that we cannot conclude a cause effect relationship between ATC or GTA haplotypes and DN onset.
Second, serum IL-10 level was not analyzed, thus, in this population;
it is unknown whether IL10 haplotype correlate with IL-10 levels.
| CON CLUS IONS
In summary, the present study suggests that IL10 promoter haplotypes play an important role in the susceptibility to DN in the western Mexican population. Nevertheless, to elucidate IL10 ATC and GTA haplotypes role in DN, additional in vitro studies will be needed to evaluate the haplotype effect on IL-10 serum levels.
